Vaccinology in sub-Saharan Africa
Open Access
- 20 September 2019
- journal article
- research article
- Published by BMJ in BMJ Global Health
- Vol. 4 (5) , e001363
Abstract
We undertook a landscape analysis of vaccinology research and training in sub-Saharan Africa in order to identify key gaps and opportunities for capacity development in the field . We conducted interviews with regional and global immunisation experts, reviewed university and research centre websites, searched the scientific literature and analysed donor databases as part of our mapping exercise. We found that (1) few vaccinology training programmes are available in the region; (2) vaccinology research sites are numerous but unevenly distributed across countries and subregions and of widely varying capacity; (3) donor funding favours HIV, tuberculosis and malaria vaccine development over other high-burden diseases; (4) lack of vaccine design, manufacturing and regulatory capacity slows the progress of new vaccines through the research and development pipeline and (5) vaccine implementation research garners limited support. Regional efforts to strengthen African vaccinology expertise should develop advanced vaccinology training programmes, support clinical trial and implementation research sites in geographic areas with limited capacity and conduct multidisciplinary research to help design, license and roll out new vaccines.Keywords
Funding Information
- Bill and Melinda Gates Foundation (OPP1147868)
This publication has 7 references indexed in Scilit:
- Immunogenicity of Fractional-Dose Vaccine during a Yellow Fever Outbreak — Final ReportNew England Journal of Medicine, 2019
- Fractional-Dose Yellow Fever Vaccination — Advancing the Evidence BaseNew England Journal of Medicine, 2018
- Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trialThe Lancet Infectious Diseases, 2018
- When less is more: how many doses of PCV are enough?The Lancet Infectious Diseases, 2018
- Aedes Mosquitoes and Aedes-Borne Arboviruses in Africa: Current and Future ThreatsInternational Journal of Environmental Research and Public Health, 2018
- Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- Cholera Outbreaks in Africa2014